Gray matter abnormalities in autism spectrum disorder revealed by T2 relaxation.

Department of Radiology, University of Washington School of Medicine, Seattle 98105, USA.
Neurology (Impact Factor: 8.3). 09/2006; 67(4):632-6. DOI: 10.1212/01.wnl.0000229923.08213.1e
Source: PubMed

ABSTRACT To perform quantitative T2 relaxation measurements to evaluate cerebral water content in children with autism.
Sixty 2- to 4-year-old children with autism spectrum disorder (ASD), 16 age-matched children with idiopathic developmental delay (DD), and 10 children with typical development (TD) were scanned on a 1.5 T GE MRI scanner to obtain dual-echo fast spin echo images (2.5 mm thick, 0-mm gap). Images were segmented into gray and white matter and used to mask regions of interest for calculating T2 for each tissue type. Analysis of variance, covarying for age and sex, was used to compare T2 between groups, and correlations were used to compare T2 to IQ measures.
Children with ASD had prolonged cortical gray matter T2, but white matter T2 was not significantly different, compared with the children with TD. T2 was prolonged in cortical gray matter and white matter in children with DD compared with children with ASD or TD. Significant interactions between T2 measures and IQ were not observed.
Prolonged gray and white matter T2 in the children with developmental delay likely represents a delay in neuronal development and maturation. Prolonged T2 in gray matter, but not white matter, observed in children with autism spectrum disorder may signify abnormal developmental processes specific to autism.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: HBOT and Autism Overview At first glance, the use of hyperbaric oxy-gen therapy (HBOT) in autism appears out of the ordinary. That is what I first thought when I heard about HBOT and autism almost 2 years ago. At the time, no studies existed on the use of HBOT in au-tistic individuals (there was one published case re-port [1]). In fact, many people who were propo-nents for this therapy could not give a theoretical reason why it should/could even work. We began using HBOT in autistic children with a great deal of skepticism. After seeing improvements in some of these children, we decided that further study was needed. Just over 2 years later, we have finished our third study on the use of HBOT in autism. Many of the underlying pathophysiological findings in autism might be ameliorable with HBOT and these have been reviewed in another publication [2]. HBOT in children is generally regarded as safe [3]. Cerebral Hypoperfusion in Autism To understand how or why HBOT works in autistic children, we need to review some basic, but newly described, fundamental problems found in many autistic individuals. There are now numer-ous studies in the medical literature [4-11] demon-strating cerebral hypoperfusion (decreased blood flow in the brain) in as many as 86% of autistic individuals [4]. In one study, this hypoperfusion typically worsened as the age of the autistic child increased, and become "quite profound" in older children compared to younger [5]. Furthermore, this diminished blood flow typically correlates with many core autistic symptoms (see Table 1). When a neurotypical person has to focus on a task or gen-erate speech (in other words, when the brain has to do work), there is an increase in blood flow to the brain, supplying more blood, oxygen, and glucose (fuel) [12]. However, several studies have now demonstrated that not only do some autistic children have diminished blood flow at baseline, they also do not get an increase in blood flow when brain cells have to do more work, such as when the chil-dren have to focus on a task or generate a sentence [13-15]. In fact, sometimes cerebral blood flow goes down and this appears to be mediated, in part, by in-appropriate vasoconstriction instead of vasodilatation [15]. The interesting thing about these studies demon-strating cerebral hypoperfusion in autism is that no one has stopped to ask why the diminished blood flow exists in the first place. This cerebral hypoperfusion appears to lead to cerebral hypoxia (impaired oxygen delivery) to the brain in some autistic individuals. In fact, several studies have demonstrated a reduction of Bcl-2 and an increase of p53 in the brain of some au-tistic individuals [80, 81]. Elevated p53 is caused by hypoxia [82] and an increase in Bcl-2 normally pro-tects from cell death provoked by hypoxia; a reduction is associated with increased damage caused by hy-poxia [83].
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The morphological alterations of cortical lamination observed in mouse models of developmental hypothyroidism prompted the recognition that these experimental changes resembled the brain lesions of children with autism; this led to recent studies showing that maternal thyroid hormone deficiency increases fourfold the risk of autism spectrum disorders (ASD), offering for the first time the possibility of prevention of some forms of ASD. For ethical reasons, the role of thyroid hormones on brain development is currently studied using animal models, usually mice and rats. Although mammals have in common many basic developmental principles regulating brain development, as well as fundamental basic mechanisms that are controlled by similar metabolic pathway activated genes, there are also important differences. For instance, the rodent cerebral cortex is basically a primary cortex, whereas the primary sensory areas in humans account for a very small surface in the cerebral cortex when compared to the associative and frontal areas that are more extensive. Associative and frontal areas in humans are involved in many neurological disorders, including ASD, attention deficit-hyperactive disorder, and dyslexia, among others. Therefore, an evo-devo approach to neocortical evolution among species is fundamental to understand not only the role of thyroid hormones and environmental thyroid disruptors on evolution, development, and organization of the cerebral cortex in mammals but also their role in neurological diseases associated to thyroid dysfunction.
    Frontiers in Endocrinology 09/2014; 5:146.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite the widely-held understanding that the biological changes that lead to autism usually occur during prenatal life, there has been relatively little research into the functional development of the brain during early infancy in individuals later diagnosed with autism spectrum disorder (ASD). This review explores the studies over the last three years which have investigated differences in various brain regions in individuals with ASD or who later go on to receive a diagnosis of ASD. We used PRISMA guidelines and selected published articles reporting any neurological abnormalities in very early childhood in individuals with or later diagnosed with ASD. Various brain regions are discussed including; the amygdala; cerebellum; frontal cortex and lateralised abnormalities of the temporal cortex during language processing. This review discusses studies investigating head circumference, electrophysiological markers and inter-hemispheric synchronisation. All the recent findings from the beginning of 2009 across these different aspects of defining neurological abnormalities are discussed in light of earlier findings. The studies across these different areas reveal the existence of atypicalities in the first year of life, well before ASD is reliably diagnosed. Cross-disciplinary approaches are essential to elucidate the pathophysiological sequence of events that lead to ASD.
    Behavioural neurology 08/2013; · 1.64 Impact Factor

Full-text (2 Sources)

Available from
May 17, 2014